RecruitingEarly Phase 1NCT05705414

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

Oral Intradialytic Amino Acids Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis (OASIS)


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

28 participants

Start Date

Oct 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.


Eligibility

Min Age: 18 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether taking amino acid supplements (the building blocks of protein) during hemodialysis sessions can improve strength and energy levels in people with end-stage kidney disease who require dialysis three times a week. **You may be eligible if...** - You are between 18 and 64 years old - You have end-stage kidney disease and have been on hemodialysis three times a week for at least 6 months **You may NOT be eligible if...** - You have an allergy to amino acids or the supplement ingredients - You have recently had a documented COVID-19 infection - You are already taking amino acid or protein supplements - You have active substance use issues (alcohol, drugs) - You have active heart failure, active cancer treatment, or major depressive disorder being treated with antidepressants - You have chronic liver disease - You have a stroke with lasting disability - You have conditions affecting hand strength that would prevent completing grip tests Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGValine

A medical food intended for use under medical supervision

DRUGEEA

A medical food intended for use under medical supervision


Locations(1)

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05705414


Related Trials